OrbiMed Genesis GP LLC, Director, 10% Owner at Edgewise Therapeutics, Inc. (EWTX), bought 993,542 shares at $20.13 ($20.0M) on 2025-04-03, disclosed to the SEC on 2025-04-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.13 | 124,193 | $2.5M | 12.5% |
| 2 | $20.13 | 124,193 | $2.5M | 12.5% |
| 3 | $20.13 | 372,578 | $7.5M | 37.5% |
| 4 | $20.13 | 372,578 | $7.5M | 37.5% |
| Total | $20.13 avg | 993,542 | $20.0M | 100% |
| Filing → |
| KROS | SELL | 2024-08-15 | $11.0M | — | Filing → |
| TERN | SELL | 2024-07-17 | $562K | — | Filing → |
| IRON | BUY | 2024-06-20 | $3.0M | — | Filing → |